Beyaz^®: an oral contraceptive fortified with folate

ISSN： 1745-5057

Source： Women's Health, Vol.8, Iss.1, 2012-01, pp. : 13-19

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Non-oral reversible contraceptive methods

By Simon Melissa Shulman Lee P

Women's Health, Vol. 2, Iss. 1, 2006-01 ,pp. : 167-177

Future Medicine

Access to resources Recommend Favorite

Oral Contraceptive‐induced Lupus Erythematosus in a Japanese Woman

THE JOURNAL OF DERMATOLOGY, Vol. 18, Iss. 1, 1991-01 ,pp. : 56-58

John Wiley & Sons Inc

Access to resources Recommend Favorite

Serum lipids during oral contraceptive exposure

CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol. 11, Iss. 2, 1970-03 ,pp. : 188-193

John Wiley & Sons Inc

Access to resources Recommend Favorite

Effect of a combined oral contraceptive on patency of arterial anastomosis in a female rat model

MICROSURGERY (ELECTRONIC), Vol. 35, Iss. 7, 2015-10 ,pp. : 553-559

John Wiley & Sons Inc

Access to resources Recommend Favorite

Oral contraceptive use and bone mass in women aged 26–36 years

By Wei S. Jones G. Thomson R. Dwyer T. Venn A.

Osteoporosis International, Vol. 22, Iss. 1, 2011-01 ,pp. : 351-355

Springer Publishing Company

Access to resources Recommend Favorite